NR605 ADVANCED PHARMACOLOGY
MIDTERM EXAM QUESTIONS AND
ANSWERS 2026/2027 UPDATE || 100%
GUARANTEED PASS
1. A patient with chronic kidney disease (CKD) requires an adjustment in their medication
dosage. Which pharmacokinetic parameter is most significantly affected by a decrease in
glomerular filtration rate?
A. Volume of distribution
B. Hepatic metabolism
C. Renal clearance
D. Absorption rate
Answer: C
Conceptual Explanation: Renal clearance is the volume of plasma cleared of a drug per
unit time by the kidneys. Decreased GFR directly reduces renal clearance, leading to drug
accumulation if doses are not adjusted.
2. Which of the following best describes the ‘First-Pass Effect’ in pharmacology?
A. The rapid excretion of a drug by the kidneys immediately after absorption.
B. The metabolic breakdown of a drug in the liver before it reaches systemic circulation.
,C. The initial binding of a drug to plasma proteins like albumin.
D. The process of drug distribution to the central nervous system.
Answer: B
Conceptual Explanation: The first-pass effect occurs when an orally administered drug is
absorbed from the GI tract and enters the portal circulation, where it is metabolized by the
liver before reaching the rest of the body.
3. A patient is prescribed a drug that is a known substrate of the CYP3A4 enzyme. If they
concurrently start taking a potent CYP3A4 inhibitor, what is the likely outcome?
A. Reduced risk of toxicity
B. Decreased therapeutic effect of the substrate drug
C. Increased plasma concentrations of the substrate drug
D. Rapid induction of liver enzymes
Answer: C
Conceptual Explanation: CYP3A4 inhibitors slow down the metabolism of substrate
drugs, leading to higher plasma concentrations and an increased risk of toxicity.
4. Which pharmacological term describes the concentration of a drug required to produce
50% of its maximal effect?
A. Potency (EC50)
B. Efficacy
, C. Therapeutic Index
D. Bioavailability
Answer: A
Conceptual Explanation: Potency refers to the amount of drug needed to produce a
specific intensity of effect; EC50 is the standard measure for potency.
5. A drug has a half-life of 6 hours. If a steady state is achieved after approximately 4 to 5
half-lives, how long will it take for this drug to reach steady state?
A. 12-18 hours
B. 48-60 hours
C. 6-12 hours
D. 24-30 hours
Answer: D
Conceptual Explanation: Steady state is reached after 4-5 half-lives. 4 x 6 = 24 hours and
5 x 6 = 30 hours.
6. Which medication class is contraindicated in patients with a history of angioedema related
to previous ACE inhibitor therapy?
A. Beta-blockers
B. Thiazide diuretics
C. Calcium Channel Blockers
MIDTERM EXAM QUESTIONS AND
ANSWERS 2026/2027 UPDATE || 100%
GUARANTEED PASS
1. A patient with chronic kidney disease (CKD) requires an adjustment in their medication
dosage. Which pharmacokinetic parameter is most significantly affected by a decrease in
glomerular filtration rate?
A. Volume of distribution
B. Hepatic metabolism
C. Renal clearance
D. Absorption rate
Answer: C
Conceptual Explanation: Renal clearance is the volume of plasma cleared of a drug per
unit time by the kidneys. Decreased GFR directly reduces renal clearance, leading to drug
accumulation if doses are not adjusted.
2. Which of the following best describes the ‘First-Pass Effect’ in pharmacology?
A. The rapid excretion of a drug by the kidneys immediately after absorption.
B. The metabolic breakdown of a drug in the liver before it reaches systemic circulation.
,C. The initial binding of a drug to plasma proteins like albumin.
D. The process of drug distribution to the central nervous system.
Answer: B
Conceptual Explanation: The first-pass effect occurs when an orally administered drug is
absorbed from the GI tract and enters the portal circulation, where it is metabolized by the
liver before reaching the rest of the body.
3. A patient is prescribed a drug that is a known substrate of the CYP3A4 enzyme. If they
concurrently start taking a potent CYP3A4 inhibitor, what is the likely outcome?
A. Reduced risk of toxicity
B. Decreased therapeutic effect of the substrate drug
C. Increased plasma concentrations of the substrate drug
D. Rapid induction of liver enzymes
Answer: C
Conceptual Explanation: CYP3A4 inhibitors slow down the metabolism of substrate
drugs, leading to higher plasma concentrations and an increased risk of toxicity.
4. Which pharmacological term describes the concentration of a drug required to produce
50% of its maximal effect?
A. Potency (EC50)
B. Efficacy
, C. Therapeutic Index
D. Bioavailability
Answer: A
Conceptual Explanation: Potency refers to the amount of drug needed to produce a
specific intensity of effect; EC50 is the standard measure for potency.
5. A drug has a half-life of 6 hours. If a steady state is achieved after approximately 4 to 5
half-lives, how long will it take for this drug to reach steady state?
A. 12-18 hours
B. 48-60 hours
C. 6-12 hours
D. 24-30 hours
Answer: D
Conceptual Explanation: Steady state is reached after 4-5 half-lives. 4 x 6 = 24 hours and
5 x 6 = 30 hours.
6. Which medication class is contraindicated in patients with a history of angioedema related
to previous ACE inhibitor therapy?
A. Beta-blockers
B. Thiazide diuretics
C. Calcium Channel Blockers
